MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-06-0002020
Andhra Medi Pharma India Private Limited - chemicals and materials in Vijayawada, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹76.02 Cr
▲ 26% YoY
Net profit · FY 2025
₹1.23 Cr
Net margin 1.6%
EBITDA · FY 2025
₹4.52 Cr
EBITDA margin 5.9%
Authorised capital
₹2.25 Cr
Registered with MCA
Paid-up capital
₹2.25 Cr
Issued & subscribed
Open charges
₹18.15 Cr
Secured borrowings
Company age
17 yrs
Est. 2009
Employees · EPFO
89
Provident fund records
About Andhra Medi Pharma India Private Limited
Data last updated:
Andhra Medi Pharma India Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the organic chemicals and compounds segment of the chemicals and materials sector. It was incorporated on 26 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24233AP2009PTC065969. Its GSTIN is 37AAICA0961D1ZX (Andhra Pradesh).
The company has an authorised share capital of ₹2.25 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors including Kolathur Srinarayanan and Burugupalli Srinivas.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No:40 – 25 – 35/1 Opp Kesava Towres Ashram Street Patamata Lanka, Vijayawada, Andhra Pradesh, India – 520010.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.02 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.23 Cr (net margin 1.6%) and EBITDA of ₹4.52 Cr (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 17% over five years.
The company has about 89 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Andhra Medi Pharma. As per MCA filings, the company has open charges of ₹18.15 Cr on record. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.24 Cr; the latest was in March 2022.
Andhra Medi Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-06-0002020). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ampil.in.
Company details
CIN U24233AP2009PTC065969
Registration Number 065969
Incorporation Date 26 November 2009
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-06-0002020
Key People
Kolathur Srinarayanan Director Burugupalli Srinivas Director Garikipati Kishore Kumar Director Recognitions & Rankings of Andhra Medi Pharma India
Contact details
Andhra Medi Pharma India Private Limited's registered office is in Vijayawada, Andhra Pradesh. Its website is ampil.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD.No:40 – 25 – 35/1 Opp Kesava Towres Ashram Street Patamata Lanka, Vijayawada, Andhra Pradesh, India – 520010
- IndustryChemicals and Materials, Organic Chemicals & Compounds
To see the full contact details of Andhra Medi Pharma India Private Limited, buy the company report.
Comprehensive company report
Andhra Medi Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Andhra Medi Pharma India operates one associated brand: Andhra Medi Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of Active Pharmaceutical Ingredients, Bulk Intermediates, and Nutraceuticals from agricultural byproducts in India. | ampil.in |
Business activity
The main business activity of Andhra Medi Pharma India is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Andhra Medi Pharma India Private Limited, buy the company report.
Financials of Andhra Medi Pharma India Private Limited
FY 2024 filings availableAndhra Medi Pharma India Private Limited reported revenue of ₹76.02 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹76.02 Cr ▲ 26%
Net profit · FY 2025
₹1.23 Cr margin 1.6%
EBITDA · FY 2025
₹4.52 Cr margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 2%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 4%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 26% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Andhra Medi Pharma India Private Limited, buy the company report.
Board of directors of Andhra Medi Pharma India Private Limited
Andhra Medi Pharma India has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kolathur Srinarayanan | Director | 03 Dec 2010 | 15 Years 10 Months | Current |
| Burugupalli Srinivas Also directs: Balaji Aqua and Poultry Feed LLP, Biofern Life Sciences Private Limited, Quantlytix Private Limited and 1 more | Director | 03 Dec 2010 | 15 Years 10 Months | Current |
| Garikipati Kishore Kumar | Director | 15 Apr 2011 | 15 Years 6 Months | Current |
| Anjana Chilakapati | Director | 26 Nov 2009 | 16 Years 11 Months | Current |
| Sirigina Srinivasa Rao | Director | 15 Apr 2011 | 15 Years 6 Months | Current |
| Rajeev Chilakapati Also directs: Sri Udbava Infra Developers Private Limited | Director | 26 Nov 2009 | 16 Years 11 Months | Current |
Auditor
Andhra Medi Pharma India Private Limited is audited by DANADAMUDI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DANADAMUDI & ASSOCIATES | FY 2023 | 009446S |
Shareholding
The shareholding of Andhra Medi Pharma India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Andhra Medi Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2022 | 100619399 | Indian Bank | ₹3.5 Cr | Open | |
| 14 Jul 2022 | 100601092 | Indian Bank | ₹1.16 Cr | Open | |
| 14 Jul 2020 | 100351599 | Indian Bank | ₹99 Lakh | Open | |
| 20 Apr 2011 | 10285586 | Indian Bank | ₹12.5 Cr | Open |
To see the full charge records of Andhra Medi Pharma India Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Andhra Medi Pharma India Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.24 Cr; the latest was in March 2022.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹2.24 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Mar 2012 | Funding round | ₹2.24 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Andhra Medi Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Andhra Medi Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Andhra Medi Pharma India Private Limited has a workforce of 89 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
89
Active EPFO establishments
1
Employee growth
-4.3%
GST
Andhra Medi Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAICA0961D1ZX | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Andhra Medi Pharma India Private Limited, buy the company report.
Recent activity
Andhra Medi Pharma India Private Limited has 8 board changes on record since 2009: 6 appointments and 2 cessations. The latest: Burugupalli Srinivas ceased to be Additional Director on 26 Sep 2011.
AGM
Andhra Medi Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Andhra Medi Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
A charge with Indian Bank amounted to Rs. 3.50 Cr with Charge ID 100619399 was registered on 07 Sep 2022.
Charges
A charge with Indian Bank of Rs. 12.50 Cr registered on 20 Apr 2011 with Charge ID 10285586 was modified on 07 Sep 2022.
Charges
A charge with Indian Bank amounted to Rs. 1.16 Cr with Charge ID 100601092 was registered on 14 Jul 2022.
Charges
A charge with Indian Bank amounted to Rs. 0.99 Cr with Charge ID 100351599 was registered on 14 Jul 2020.
Ceased
Burugupalli Srinivas ceased to be Additional Director.
Ceased
Kolathur Srinarayanan ceased to be Additional Director.
Charges
A charge with Indian Bank amounted to Rs. 12.50 Cr with Charge ID 10285586 was registered on 20 Apr 2011.
Appointed
Garikipati Kishore Kumar was appointed as Director.
Appointed
Sirigina Srinivasa Rao was appointed as Director.
Appointed
Burugupalli Srinivas was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Andhra Medi Pharma India is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in organic chemicals and compounds, within the chemicals and materials industry. It was incorporated on 26 November 2009 (17+ years old) and is registered under CIN U24233AP2009PTC065969.
Andhra Medi Pharma India has 6 current directors:
- Kolathur Srinarayanan - Director
- Burugupalli Srinivas - Director
- Garikipati Kishore Kumar - Director
- Anjana Chilakapati - Director
- Sirigina Srinivasa Rao - Director
- Rajeev Chilakapati - Director
The latest financial statements of Andhra Medi Pharma India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Andhra Medi Pharma India is 37AAICA0961D1ZX, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Andhra Medi Pharma India is U24233AP2009PTC065969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Andhra Medi Pharma India was incorporated on 26 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Vijayawada.
Andhra Medi Pharma India has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2.24 Cr; the latest was in March 2022.
Burugupalli Srinivas ceased to be Additional Director on 26 Sep 2011. Kolathur Srinarayanan ceased to be Additional Director on 26 Sep 2011. Garikipati Kishore Kumar was appointed as Director on 15 Apr 2011. Andhra Medi Pharma India has 8 board changes on record in total.
Yes, Andhra Medi Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-AP-06-0002020).
Andhra Medi Pharma India can be reached through the website ampil.in. Its registered office is in Vijayawada, Andhra Pradesh, India.